Porcine Filler for Facial Lipoatrophy Associated With Human Immunodeficiency Virus Treatment
Identifieur interne : 001E88 ( Main/Exploration ); précédent : 001E87; suivant : 001E89Porcine Filler for Facial Lipoatrophy Associated With Human Immunodeficiency Virus Treatment
Auteurs : Natalie Reytan [Allemagne] ; Berthold Rzany [Allemagne]Source :
- Journal of drugs in dermatology [ 1545-9616 ] ; 2008.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Association.
English descriptors
- KwdEn :
Abstract
Background: Facial lipoatrophy is a common problem for patients with human immunodeficiency virus (HIV) treated with highly active antiretroviral therapy (HAART). The loss of subcutaneous facial tissue occurs in the cheeks, temples, and periocular region. Facial lipoatrophy is a stigmatizing feature of HIV. The effective treatment can provide psychosocial stress for the patient. Objective: To report on the experience using a novel porcine collagen filler in the treatment of a patient with HIV-associated facial lipoatrophy. Physician observations and photographs for documentation were collected up to 14 months posttreatment. Methods: A patient with HIV with facial lipoatrophy was treated with a novel collagen injectable filler derived from porcine collagen. Results: After 4 treatment sessions over 7 months using the novel porcine collagen injectable filler, significant improvement was found and dermal thickening was retained in the area of the cheeks for an additional 7 months. Conclusion: As facial lipoatrophy is a very stigmatizing manifestation of HIV, volume augmentation is highly beneficial. Using a novel porcine collagen, a natural outcome was obtained that lasted for over 4 months. Additional studies should be conducted to further investigate the use of a novel porcine collagen in the treatment of HIV-associated facial lipoatrophy.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000144
- to stream PascalFrancis, to step Curation: 000135
- to stream PascalFrancis, to step Checkpoint: 000103
- to stream Main, to step Merge: 001E90
- to stream Main, to step Curation: 001E88
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Porcine Filler for Facial Lipoatrophy Associated With Human Immunodeficiency Virus Treatment</title><author><name sortKey="Reytan, Natalie" sort="Reytan, Natalie" uniqKey="Reytan N" first="Natalie" last="Reytan">Natalie Reytan</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Venerologie und Allergologie</s1><s2>Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Rzany, Berthold" sort="Rzany, Berthold" uniqKey="Rzany B" first="Berthold" last="Rzany">Berthold Rzany</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Venerologie und Allergologie</s1><s2>Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">09-0073140</idno><date when="2008">2008</date><idno type="stanalyst">PASCAL 09-0073140 INIST</idno><idno type="RBID">Pascal:09-0073140</idno><idno type="wicri:Area/PascalFrancis/Corpus">000144</idno><idno type="wicri:Area/PascalFrancis/Curation">000135</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000103</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000103</idno><idno type="wicri:doubleKey">1545-9616:2008:Reytan N:porcine:filler:for</idno><idno type="wicri:Area/Main/Merge">001E90</idno><idno type="wicri:Area/Main/Curation">001E88</idno><idno type="wicri:Area/Main/Exploration">001E88</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Porcine Filler for Facial Lipoatrophy Associated With Human Immunodeficiency Virus Treatment</title><author><name sortKey="Reytan, Natalie" sort="Reytan, Natalie" uniqKey="Reytan N" first="Natalie" last="Reytan">Natalie Reytan</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Venerologie und Allergologie</s1><s2>Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Rzany, Berthold" sort="Rzany, Berthold" uniqKey="Rzany B" first="Berthold" last="Rzany">Berthold Rzany</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Venerologie und Allergologie</s1><s2>Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author></analytic><series><title level="j" type="main">Journal of drugs in dermatology</title><title level="j" type="abbreviated">J. drugs dermatol.</title><idno type="ISSN">1545-9616</idno><imprint><date when="2008">2008</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of drugs in dermatology</title><title level="j" type="abbreviated">J. drugs dermatol.</title><idno type="ISSN">1545-9616</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term><term>Associated virus</term><term>Association</term><term>Dermatology</term><term>Face</term><term>Human immunodeficiency virus</term><term>Lipoatrophy</term><term>Pig</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Lipoatrophie</term><term>SIDA</term><term>Porc</term><term>Face</term><term>Association</term><term>Virus associé</term><term>Virus immunodéficience humaine</term><term>Traitement</term><term>Dermatologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Association</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Facial lipoatrophy is a common problem for patients with human immunodeficiency virus (HIV) treated with highly active antiretroviral therapy (HAART). The loss of subcutaneous facial tissue occurs in the cheeks, temples, and periocular region. Facial lipoatrophy is a stigmatizing feature of HIV. The effective treatment can provide psychosocial stress for the patient. Objective: To report on the experience using a novel porcine collagen filler in the treatment of a patient with HIV-associated facial lipoatrophy. Physician observations and photographs for documentation were collected up to 14 months posttreatment. Methods: A patient with HIV with facial lipoatrophy was treated with a novel collagen injectable filler derived from porcine collagen. Results: After 4 treatment sessions over 7 months using the novel porcine collagen injectable filler, significant improvement was found and dermal thickening was retained in the area of the cheeks for an additional 7 months. Conclusion: As facial lipoatrophy is a very stigmatizing manifestation of HIV, volume augmentation is highly beneficial. Using a novel porcine collagen, a natural outcome was obtained that lasted for over 4 months. Additional studies should be conducted to further investigate the use of a novel porcine collagen in the treatment of HIV-associated facial lipoatrophy.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Berlin</li></region><settlement><li>Berlin</li></settlement></list><tree><country name="Allemagne"><region name="Berlin"><name sortKey="Reytan, Natalie" sort="Reytan, Natalie" uniqKey="Reytan N" first="Natalie" last="Reytan">Natalie Reytan</name></region><name sortKey="Rzany, Berthold" sort="Rzany, Berthold" uniqKey="Rzany B" first="Berthold" last="Rzany">Berthold Rzany</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E88 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E88 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:09-0073140
|texte= Porcine Filler for Facial Lipoatrophy Associated With Human Immunodeficiency Virus Treatment
}}
| This area was generated with Dilib version V0.6.33. |  |